NYSE : INSP
Inspire Medical Systems, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 71.18 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.06B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.97B |
| Enterprise Value | 1.68B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 2, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 28.91M |
| Shares Outstanding | 28.91M |
| Shares Change (YoY) | -3.84% |
| Shares Change (QoQ) | +0.84% |
| Owned by Insiders (%) | 1.27% |
| Owned by Institutions (%) | 111.10% |
| Float | 23.28M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 14.78 |
| Forward PE | 50.09 |
| PS Ratio | 2.19 |
| Forward PS | 2.28 |
| PB Ratio | 2.38 |
| P/TBV Ratio | 2.38 |
| P/FCF Ratio | 16.81 |
| P/OCF Ratio | 12.53 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 12.42 |
| EV / Sales | 1.87 |
| EV / EBITDA | 23.51 |
| EV / EBIT | 30.99 |
| EV / FCF | 14.32 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 8.55 |
| Quick Ratio | 5.96 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.37 |
| Debt / FCF | 0.25 |
| Interest Coverage | 395.06 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 17.96% |
| Return on Assets (ROA) | 3.91% |
| Return on Invested Capital (ROIC) | 10.10% |
| Return on Capital Employed (ROCE) | 6.33% |
| Weighted Average Cost of Capital (WACC) | 8.16% |
| Revenue Per Employee | $674,225 |
| Profits Per Employee | $101,307 |
| Employee Count | 1,333 |
| Asset Turnover | 1.04 |
| Inventory Turnover | 0.85 |
Taxes
| Measure | Value |
|---|
| Income Tax | -65.66M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.73 |
| 52-Week Price Change | -9.41% |
| 50-Day Moving Average | 68.59 |
| 200-Day Moving Average | 58.57 |
| Relative Strength Index (RSI) | 45.35 |
| Average Volume (20 Days) | 703,226 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 4.49M |
| Short Previous Month | 3.93M |
| Short % of Shares Out | 15.54% |
| Short % of Float | 19.30% |
| Short Ratio (days to cover) | 4.74 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 898.74M |
| Gross Profit | 774.11M |
| Operating Income | 54.12M |
| Pretax Income | 69.38M |
| Net Income | 135.04M |
| EBITDA | 71.33M |
| EBIT | 54.12M |
| Earnings Per Share (EPS) | $4.61 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 320.68M |
| Total Debt | 29.09M |
| Net Cash | 291.59M |
| Net Cash Per Share | $10.09 |
| Equity (Book Value) | 825.58M |
| Book Value Per Share | 28.56 |
| Working Capital | 537.49M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 157.07M |
| Capital Expenditures | -39.98M |
| Depreciation & Amortization | 17.21M |
| Net Borrowing | n/a |
| Free Cash Flow | 117.09M |
| FCF Per Share | $4.05 |
Margins
| Measure | Value |
|---|
| Gross Margin | 86.13% |
| Operating Margin | 6.02% |
| Pretax Margin | 7.72% |
| Profit Margin | 15.03% |
| EBITDA Margin | 7.94% |
| EBIT Margin | 6.02% |
| FCF Margin | 13.03% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 3.84% |
| Shareholder Yield | 3.84% |
| Earnings Yield | 6.77% |
| FCF Yield | 5.95% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $68.00 |
| Price Target Difference | -0.15% |
| Analyst Consensus | Hold |
| Analyst Count | 18 |
| Revenue Growth Forecast (3Y) | 1.27% |
| EPS Growth Forecast (3Y) | -6.68% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 15.39 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |